Skip to content

Study of the Safety and Efficacy of an Iontophoretic Device to Treat Recurrent Herpes Labialis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN83097613
Enrollment
13
Registered
2005-09-29
Start date
2003-07-22
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent herpes Infections and Infestations Herpes labialis

Interventions

In this study, 13 subjects with a history of herpes labialis used both a test and a placebo device in two separate episodes in order to treat HSV lesions. The stages of the lesions were frequently as

Sponsors

Klearsen Corporation (USA)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 years or greater 2. Peri-oral HSV occurring four or more times per year

Exclusion criteria

Exclusion criteria: 1. No serious medical illness 2. No use of systemic immunosuppressive therapy 3. No significant dermatological illness on the face 4. No known allergy to metal ions or components of the electrolyte ointment 5. No antiviral therapy in the 7 days prior to an outbreak and during the outbreak 6. Must forego other treatments for HSV during an outbreak 7. Must forego use of lipstick or other emollients to cover a peri-oral HSV lesion

Design outcomes

Primary

MeasureTime frame
Reduction in the time until the cessation of pain and reduction in the time until healed lesion healed.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026